Lorazepam in the treatment of severe anxiety and anxiety associated with psychotic conditions.
D000328:Adult; D000374:Aggression / Q000188:drug therapy; D000639:Amitriptyline / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D001259:Ataxia / Q000139:chemically induced; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D003975:Diazepam / Q000008:administration & dosage; D004329:Droperidol / Q000627:therapeutic use; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D011395:Promazine / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000517:prevention & control; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D014149:Tranquilizing Agents; D000639:Amitriptyline; D008728:Methotrimeprazine; D011395:Promazine; D004329:Droperidol; D003975:Diazepam